Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 135 B, Issue 1, 2005, Pages 94-101

  Lundorf, M D ^a   Buttenschon, H N ^a   Foldager, L ^a   Blackwood, D H R ^b   Muir, W J ^b   Murray, V ^c   Pelosi, A J ^d   Kruse, T A ^e   Ewald, H ^a   Mors, O ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d HAIRMYRES HOSPITAL   (United Kingdom)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Association; Bipolar affective disorder; Glutamate decarboxylase 1; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DENMARK; EXON; GAD1 GENE; GAD67 GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; DENMARK; DNA; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA;

EID: 20244366232     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30137     Document Type: Article

References (52)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. 1995. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266.
2. Ambrosius WT, Lange EM, Langefeld CD. 2004. Power for genetic association studies with random allele frequencies and genotype distributions. Am J Hum Genet 74:683-693.
3. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association.
4. Benes FM, Berretta S. 2001. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27.
5. Berrettini WH. 2000. Susceptibility loci for bipolar disorder: Overlap with inherited vulnerability to schizophrenia. Biol Psychiatry 47:245-251.
6. Borglum AD, Bruun TG, Kjeldsen TE, Ewald H, Mors O, Kirov G, Russ C, Freeman B, Collier DA, Kruse TA. 1999. Two novel variants in the DOPA decarboxylase gene: Association with bipolar affective disorder. Mol Psychiatry 4:545-551.
7. Bramon E, Sham PC. 2001. The common genetic liability between schizophrenia and bipolar disorder: A review. Curr Psychiatry Rep 3: 332-337.
8. Brunn TG, Ewald H. 1999. Selection bias of susceptibility genes possible when using parent-offspring trios in genetic association studies. Mol Psychiatry 4:415-416.
9. Bu DF, Tobin AJ. 1994. The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics 21:222-228.
10. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ. 1992. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89:2115-2119.
11. Buetow KH, Edmonson MN, Cassidy AB. 1999. Reliable identification of large numbers of candidate SNPs from public EST data. Nat Genet 21: 323-325.
12. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. 2001. Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence. Annu Rev Pharmacol Toxicol 41:237-260.
13. Chessler SD, Lernmark A. 2000. Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues. J Biol Chem 275:5188-5192.
14. Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K, Hemmer S, Schulze TG, Schmidt-Wolf G, Albus M, Borrmann-Hassenbach M, Franzek E, Lanczik M, Fritze J, Kreiner R, Reuner U, Weigelt B, Minges J, Lichtermann D, Lerer B, Kanyas K, Baur MP, Wienker TF, Maier W, Rietschel M, Propping P, Nothen MM. 2001. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 10:2933-2944.
15. Coon H, Hicks AA, Bailey ME, Hoff M, Holik J, Harvey RJ, Johnson KJ, Darlison MG, Reimherr F, Wender P. 1994. Analysis of GABAA receptor subunit genes in multiplex pedigrees with manic depression. Psychiatr Genet 4:185-191.
16. Dempster AP, Laird NM, Rubin DB. 1977. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B 39:1-38.
17. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. 2004. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76:581-592.
18. Duffy A, Turecki G, Grof P, Cavazzoni P, Grof E, Joober R, Ahrens B, Berghofer A, Muller-Oerlinghausen B, Dvorakova M, Libigerova E, Vojtechovsky M, Zvolsky P, Nilsson A, Licht RW, Rasmussen NA, Schou M, Vestergaard P, Holzinger A, Schumann C, Thau K, Robertson C, Rouleau GA, Alda M. 2000. Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder. J Psychiatry Neurosci 25:353-358.
19. Endicott J, Spitzer RL. 1978. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
20. Erlander MG, Tobin AJ. 1992. A transcriptional regulatory element of the gene encoding the 67,000-M(r) form of human glutamate decarboxylase is similar to a Drosophila regulatory element. J Neurochem 58:2182-2190.
21. Gershon ES. 2000. Bipolar illness and schizophrenia as oligogenic diseases: Implications for the future. Biol Psychiatry 47:240-244.
22. Guidotti A, Auta J, Davis JM, Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E, DiGiorgi GV. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch Gen Psychiatry 57:1061-1069.
23. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. 1998. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718-15723.
24. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Barmeier H, Mathewes S, Grant FJ, Foster D. 1991. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88:8337-8341.
25. Kelly CD, Edwards Y, Johnstone AP, Harfst E, Nogradi A, Nussey SS, Povey S, Carter ND. 1992. Nucleotide sequence and chromosomal assignment of a cDNA encoding the large isoform of human glutamate decarboxylase. Ann Hum Genet 56(Pt 3):255-265.
26. Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF. 2002. Molecular abnormalities in the major psychiatric illnesses: Classification and regression tree (CRT) analysis of post-mortem prefrontal markers. Mol Psychiatry 7:392-404.
27. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7(Suppl 1):S71-S80.
28. Lappalainen J, Sanacora G, Kranzler HR, Malison R, Hibbard ES, Price LH, Krystal J, Gelernter J. 2004. Mutation screen of the glutamate decarboxylase-67 gene and haplotype association to unipolar depression. Am J Med Genet 124B:81-86.
29. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, Helgason T. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73:34-48.
30. Lewontin AC. 1964. The interaction of selection and linkage I. General considerations: Heterotic models. Genetics 49:49-67.
31. Massat I, Souery D, Del Favero J, Oruc L, Noethen MM, Blackwood D, Thomson M, Muir W, Papadimitriou GN, Dikeos DG, Kaneva R, Serretti A, Lilli R, Smeraldi E, Jakovljevic M, Folnegovic V, Rietschel M, Milanova V, Valente F, Van Broeckhoven C, Mendlewicz J. 2002. Excess of allelel for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: A multicentric association study. Mol Psychiatry 7:201-207.
32. McGuffin P, Owen MJ, Farmer AE. 1995. Genetic basis of schizophrenia. Lancet 346:678-682.
33. Oruc L, Furac I, Croux C, Jakovljevic M, Kracun I, Folnegovic V, Van Broeckhoven C. 1996. Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: A preliminary report. Psychiatr Genet 6:213-217.
34. Oruc L, Verheyen GR, Furac I, Ivezic S, Jakovljevic M, Raeymaekers P, Van Broeckhoven C. 1997. Positive association between the GABRA5 gene and unipolar recurrent major depression. Neuropsychobiology 36: 62-64.
35. Papadimitriou GN, Dikeos DG, Karadima G, Avramopoulos D, Daskalopoulou EG, Vassilopoulos D, Stefanis CN. 1998. Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder. Am J Med Genet 81:73-80.
36. Papadimitriou G, Dikeos D, Daskalopoulou E, Karadima G, Avramopoulos D, Contis C, Stefanis C. 2001a. Association between GABA-A receptor alpha 5 subunit gene locus and schizophrenia of a later age of onset. Neuropsychobiology 43:141-144.
37. Papadimitriou GN, Dikeos DG, Karadima G, Avramopoulos D, Daskalopoulou EG, Stefanis CN. 2001b. GABA-A receptor beta3 and alpha5 subunit gene cluster on chromosome 15q11-q13 and bipolar disorder: A genetic association study. Am J Med Genet 105:317-320.
38. Potash JB, DePaulo JR Jr. 2000. Searching high and low: A review of the genetics of bipolar disorder. Bipolar Disord 2:8-26.
39. Puertollano R, Visedo G, Saiz-Ruiz J, Llinares C, Fernandez-Piqueras J. 1995. Lack of association between manic-depressive illness and a highly polymorphic marker from GABRA3 gene. Am J Med Genet 60:434-435.
40. Puertollano R, Visedo G, Zapata C, Fernandez-Piqueras J. 1997. A study of genetic association between manic-depressive illness and a highly polymorphic marker from the GABRbeta-1 gene. Am J Med Genet 74: 342-344.
41. R Development Core Team. 2004. R: A language and environment for statistical computing, Vienna, Austria: R Foundation for Statistical Computing.
42. Royston P, Babiker A. 2002. A menu-driven facility for complex sample size calculation in randomized controlled trails with survival or binary outcome. Stata J 2:151-163.
43. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434.
44. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, Craddock N, DePaulo JR, Baron M, Gershon ES, Ekholm J, Cichon S, Turecki G, Claes S, Kelsoe JR, Schofield PR, Badenhop RF, Morissette J, Coon H, Blackwood D, McInnes LA, Foroud T, Edenberg HJ, Reich T, Rice JP, Goate A, McInnis MG, McMahon FJ, Badner JA, Goldin LR, Bennett P, Willour VL, Zandi PP, Liu J, Gilliam C, Juo SH, Berrettini WH, Yoshikawa T, Peltonen L, Lonnqvist J, Nothen MM, Schumacher J, Windemuth C, Rietschel M, Propping P, Maier W, Alda M, Grof P, Rouleau GA, Del Favero J, Van Broeckhoven C, Mendlewicz J, Adolfsson R, Spence MA, Luebbert H, Adams LJ, Donald JA, Mitchell PB, Barden N, Shink E, Byerley W, Muir W, Visscher PM, Macgregor S, Gurling H, Kalsi G, McQuillin A, Escamilla MA, Reus VI, Leon P, Freimer NB, Ewald H, Kruse TA, Mors O, Radhakrishna U, Blouin JL, Antonarakis SE, Akarsu N. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 73:49-62.
45. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Di Bella D, Catalano M, Smeraldi E. 1998. GABAA alpha-1 subunit gene not associated with depressive symptomatology in mood disorders. Psychiatr Genet 8:251-254.
46. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Di Bella D, Catalano M, Smeraldi E. 1999. No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. Am J Med Genet 88:44-49.
47. Stata Corp. 2003. Stata statistical software: Release 8. College Station, TX: Stata Corporation LP.
48. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245.
49. Westmoreland JJ, McEwen J, Moore BA, Jin Y, Condie BG. 2001. Conserved function of Caenorhabditis elegans UNC-30 and mouse Pitx2 in controlling GABAergic neuron differentiation. J Neurosci 21:6810-6819.
50. Wing JK, Sartorius N, Üstün TBE. 1998. Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN.
51. Woo TU, Walsh JP, Benes FM. 2004. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61:649-657.
52. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. 2002. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79-91.